Nigeria is set to receive its first consignments of the landmark Lenacapavir, a new HIV prevention medicine, in March 2026, the federal government has disclosed.
In a statement on Monday, the National Agency for the Control of AIDS said work is already under way to introduce the injectable drug a
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
